Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2023.07.025 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Dana L Casey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: dana_casey@med.un…. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Second Primary, Neoplasms, Radiation-Induced, Sarcoma. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) analysis of published investigations of central nervous system (CNS) subsequent neoplasms (SNs), subsequent sarcomas, and subsequent lung cancers in childhood cancer survivors who received radiation therapy (RT) was performed to estimate the effect of RT dose on the risk of SNs and the modification of this risk by host and treatment factors. METHODS AND MATERIALS: A systematic literature review was performed to identify data published from 1975 to 2022 on SNs after prior RT in childhood cancer survivors. After abstract review, usable quantitative and qualitative data were extracted from 83 studies for CNS SNs, 118 for subsequent sarcomas, and 10 for lung SNs with 4 additional studies (3 for CNS SNs and 1 for lung SNs) later added. The incidences of SNs, RT dose, age, sex, primary cancer diagnosis, chemotherapy exposure, and latent time from primary diagnosis to SNs were extracted to assess the factors influencing risk for SNs. The excess relative ratio (ERR) for developing SNs as a function of dose was analyzed using inverse-variance weighted linear regression, and the ERR/Gy was estimated. Excess absolute risks were also calculated. RESULTS: The ERR/Gy for subsequent meningiomas was estimated at 0.44 (95% CI, 0.19-0.68); for malignant CNS neoplasms, 0.15 (95% CI, 0.11-0.18); for sarcomas, 0.045 (95% CI, 0.023-0.067); and for lung cancer, 0.068 (95% CI, 0.03-0.11). Younger age at time of primary diagnosis was associated with higher risk of subsequent meningioma and sarcoma, whereas no significant effect was observed for age at exposure for risk of malignant CNS neoplasm, and insufficient data were available regarding age for lung cancer. Females had a higher risk of subsequent meningioma (odds ratio, 1.46; 95% CI, 1.22-1.76; P < .0001) relative to males, whereas no statistically significant sex difference was seen in risk of malignant CNS neoplasms, sarcoma SNs, or lung SNs. There was an association between chemotherapy receipt (specifically alkylating agents and anthracyclines) and subsequent sarcoma risk, whereas there was no clear association between specific chemotherapeutic agents and risk of CNS SNs and lung SNs. CONCLUSIONS: This PENTEC systematic review shows a significant radiation dose-response relationship for CNS SNs, sarcomas, and lung SNs. Given the linear dose response, improved conformality around the target volume that limits the high dose volume might be a promising strategy for reducing the risk of SNs after RT. Other host- and treatment-related factors such as age and chemotherapy play a significant contributory role in the development of SNs and should be considered when estimating the risk of SNs after RT among childhood cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: dana_casey@med.unc.edu.
- Department of Oncology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
- Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York.
- Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.
- Division of Medical Physics, Centro di Riferimento Oncologico Aviano IRCCS, Aviano, Italy.
- Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, Massachusetts.
Zitieren
APA
Casey, D. L., Vogelius, I. R., Brodin, N. P., Roberts, K. B., Avanzo, M., Moni, J., Owens, C., Ronckers, C. M., Constine, L. S., Bentzen, S. M., & Olch, A. (2024). Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.07.025
Vancouver
Casey DL, Vogelius IR, Brodin NP, Roberts KB, Avanzo M, Moni J, et al. Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2023.07.025
BibTeX
@article{Casey2024,
author = {Casey, Dana L and Vogelius, Ivan R and Brodin, N Patrik and Roberts, Kenneth B and Avanzo, Michele and Moni, Janaki and Owens, Constance and Ronckers, Cécile M and Constine, Louis S and Bentzen, Soren M and Olch, Arthur},
title = {Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2023.07.025}
}
EUVIMED